Literature DB >> 17868037

Non-HDL cholesterol and apoB in dyslipidaemia.

Allan D Sniderman1, Jean-Charles Hogue, Jean Bergeron, Claude Gagné, Patrick Couture.   

Abstract

On the basis of a high correlation, non-HDL-C (non-high-density lipoprotein cholesterol) and apoB (apolipoprotein B) have been suggested to be of equivalent value for clinical practice; however, the strength of this relationship has not been examined in detail in patients with dyslipidaemia. The present study examines the variance of non-HDL-C compared with apoB in 1771 consecutive patients evaluated in a lipid clinic. These patients were divided into normolipidaemic subjects (n=407), type I hyperlipoproteinaemia (n=16), type IIa (n=736) and IIb (n=231) hyperlipoproteinaemia, type III hyperlipoproteinaemia (n=38), type IV hyperlipoproteinaemia (n=509) and type V hyperlipoproteinaemia (n=101). The relationship between non-HDL-C and apoB was examined both in terms of correlation and concordance. Correlation was high, but concordance was only moderate in the normolipidaemic subjects and in those with type IIa and type IIb hyperlipoproteinaemia. Correlation and concordance were both low in the subgroups with type III and type V hyperlipoproteinaemia. In those with type IV hyperlipoproteinaemia, correlation was moderately high (r=0.74), but concordance was only fair. In conclusion, our results indicate that there is substantial variance of apoB for given values of non-HDL-C in many dyslipidaemic subjects. It follows that correlation is not adequate as a sole judge of equivalence of laboratory parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17868037     DOI: 10.1042/CS20070265

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

Review 1.  ApoB versus non-HDL-C: what to do when they disagree.

Authors:  Allan Sniderman; Ken Williams; Christa Cobbaert
Journal:  Curr Atheroscler Rep       Date:  2009-09       Impact factor: 5.113

2.  Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Emil M Degoma; Mat D Davis; Richard L Dunbar; Emile R Mohler; Philip Greenland; Benjamin French
Journal:  Atherosclerosis       Date:  2013-03-26       Impact factor: 5.162

3.  Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study.

Authors:  Jacob Hartz; Ronald M Krauss; Mikael Göttsater; Olle Melander; Peter Nilsson; Michele Mietus-Snyder
Journal:  Int J Vasc Med       Date:  2020-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.